---
title: "Ginkgo Bioworks partners with Acies Bio to license Aspergillus niger strains for protein production"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294697896.md"
description: "Ginkgo Bioworks has partnered with Acies Bio in a licensing collaboration to expand global access to engineered Aspergillus niger strains for industrial protein production. The deal grants Acies customers licensed access to Ginkgo’s fungal chassis strains, combined with Acies' strain development, bioprocess scale-up, and manufacturing capabilities. Acies will utilize its SmartRoute integration to transition programs from strain to industrial output at facilities with up to 30 m3 fermentation volumes."
datetime: "2026-08-03T13:04:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294697896.md)
  - [en](https://longbridge.com/en/news/294697896.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294697896.md)
---

# Ginkgo Bioworks partners with Acies Bio to license Aspergillus niger strains for protein production

-   Ginkgo Bioworks entered a licensing collaboration with Acies Bio to expand global access to engineered Aspergillus niger strains for industrial protein production. \* Deal gives Acies customers licensed access to Ginkgo’s fungal chassis strains, paired with Acies strain development, bioprocess scale-up, validation, and manufacturing. \* Acies will use its SmartRoute integration to move programs from strain to industrial output at its facility with up to 30 m3 fermentation volumes. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ginkgo Bioworks Holdings Inc. published the original content used to generate this news brief on August 03, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [DNA.US](https://longbridge.com/en/quote/DNA.US.md)
- [DNABW.US](https://longbridge.com/en/quote/DNABW.US.md)

## Related News & Research

- [DNA: Q2 2026 revenue dropped 48% year-over-year, with major autonomous lab contracts secured](https://longbridge.com/en/news/295007946.md)
- [Is Climb Bio’s (CLYM) Mixed Loss Trends Revealing a Shift in Its Investment Story?](https://longbridge.com/en/news/296222919.md)
- [I Love Lund invests SEK 1.54 million in Aligned Bio via share subscription](https://longbridge.com/en/news/296130285.md)
- [AH Bio Fund IV Discloses Investment at Braveheart Bio with 11.4% Stake](https://longbridge.com/en/news/295977626.md)
- [Valion Bio agrees to sell 1,500 Series B preferred shares to 3i for $1.5 million in private placement](https://longbridge.com/en/news/296091036.md)